Loading...
•
Dec 31, 2020
Alphatec Q4 2020 Earnings Report
Reported Q4 and Full Year 2020 financial results and recent corporate highlights.
Key Takeaways
Alphatec Holdings, Inc. reported a 38% increase in U.S. revenue for the fourth quarter and 30% for the full year. Revenue growth has averaged approximately 30% over the past eight quarters. The company's focus on surgeon adoption and sales footprint evolution has driven market share expansion.
U.S. Revenue grew by 38% in Q4 and 30% for the full year.
New products contributed 75% of Q4 U.S. revenue, up from 48% in Q4 2019.
Q4 average U.S. revenue per case increased by 13% year-over-year.
Strategic distribution drove 47% year-over-year revenue growth in Q4.
Forward Guidance
The Company continues to expect total revenue for the fiscal year ended December 31, 2021, to approximate $178 million, which includes U.S. revenue of approximately $176 million.
Positive Outlook
- Total revenue for fiscal year ended December 31, 2021, is expected to be approximately $178 million.
- U.S. revenue for fiscal year ended December 31, 2021, is expected to be approximately $176 million.
- Revenue guidance reflects expected U.S. revenue growth of approximately 25% compared to 2020.
- Growth driven by continued launches of novel procedures and products and growing traction of the procedures and products released in 2020.
- Company expects to update guidance to reflect the positive impact of EOS imaging when that transaction closes, which is anticipated in second quarter 2021.
Challenges Ahead
- Total revenue guidance contemplates the anticipated wind-down of the Company’s international supply agreement by August 2021.
- The Company remains subject to the potential and uncertain impact of the ongoing COVID-19 pandemic.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...